Asenapine (Saphris/Sycrest®)

Asenapine (Saphris Sycrest®)

Asenapine, marketed under Saphris and Sycrest, is a medication used to treat certain mental health conditions. It belongs to a class of medications called atypical antipsychotics, which are used to treat schizophrenia and bipolar disorder.

Asenapine works by blocking the action of certain neurotransmitters in the brain, including dopamine and serotonin. Doing so helps to reduce symptoms of psychosis and stabilize mood.

Asenapine is available as sublingual tablets, placed under the tongue and allowed to dissolve. This allows the medication to enter the bloodstream quickly and start working faster than other forms of medication.

Common side effects of asenapine include drowsiness, dizziness, restlessness, and dry mouth. It may also cause weight gain, increased blood sugar levels, and an increased risk of developing diabetes. Rarely, it may cause a serious condition called a neuroleptic malignant syndrome, which can be life-threatening.

Asenapine may interact with other medications, so informing healthcare providers of all medicines, supplements, and vitamins is important. It may also increase the risk of suicidal thoughts and behaviors in some individuals, especially young adults, and teenagers, so close monitoring is required during treatment.

Overall, asenapine is a commonly prescribed medication for certain mental health conditions, and it is effective in reducing symptoms and improving the quality of life for many people. However, working closely with a healthcare provider to monitor for potential side effects or interactions is essential.

Share your support for mental health
Asenapine (Saphris Sycrest®)

Search Asenapine (Saphris/Sycrest®) Mental Health and Substance Abuse Facilities

Select State and State
State
City
Facility Focus
Language Services
Select Options
Language Services
Type Of Care
Select Options
Type Of Care
Telemedicine
Select Options
Telemedicine
Service Settings
Select Options
Service Settings
Facility Type
Select Options
Facility Type
Facility Operations
Select Options
Facility Operations
Payment Assistance Available
Select Options
Payment Assistance Available
Ancillary Services
Select Options
Ancillary Services
Tobacco/Screening Services
Select Options
Tobacco/Screening Services
Age Groups Accepted
Select Options
Age Groups Accepted
Exclusive Services
Select Options
Exclusive Services
Pharmacotherapies
Select Options
Pharmacotherapies
Treatment Approaches
Select Options
Treatment Approaches
Emergency Mental Health Services
Select Options
Emergency Mental Health Services
Special Programs/Groups Offered
Select Options
Special Programs/Groups Offered
Screening & Testing
Select Options
Screening & Testing
Insurance/Funding Accepted/Payment
Select Options
Insurance/Funding Accepted/Payment
Facility Smoking Policy
Select Options
Facility Smoking Policy
License/Accreditation
Select Options
License/Accreditation
Hospitals
Select Options
Hospitals
Type of Opioid Treatment
Select Options
Type of Opioid Treatment
Assessment/Pre-treatment
Select Options
Assessment/Pre-treatment
Transitional Services
Select Options
Transitional Services
Opioid Medications used in Treatment
Select Options
Opioid Medications used in Treatment
External Opioid Medications Source
Select Options
External Opioid Medications Source
Other Addictions
Select Options
Other Addictions
Detoxification
Select Options
Detoxification
Counseling Services and Education
Select Options
Counseling Services and Education
Medical Services
Select Options
Medical Services
Type of Alcohol Use Disorder Treatment
Select Options
Type of Alcohol Use Disorder Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Select Options
External Source of Medications Used for Alcohol Use Disorder Treatment
Gender Accepted
Select Options
Gender Accepted